Pfizer Vaccine on Track for Regulatory Review in October

    0
    29

    Pfizer Inc. and BioNTech SE said the Covid-19 vaccine they are jointly developing is on track to be submitted for regulatory review as early as October, as they released additional data from an early-stage study.The companies said the vaccine was well tolerated with mild to…

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here